Spero Therapeutics Aktie: 105 Millionen US-Dollar von Healthcare Royalty
Spero Therapeutics sichert sich frisches Kapital ohne neue Aktien auszugeben. Der Biotech-Konzern erhält 105 Millionen US-Dollar durch eine Finanzierungsvereinbarung mit Healthcare Royalty. Damit…
Read the full articlede
You might also wanna read
The Discipline of Waiting for the Fat Pitch
PIPTHEORY·just now
Solving Indonesia’s LPG subsidy challenge requires induction, not swapping fuels
ieefa.org·just now
The S&P 500 Is Flashing an Ominous Warning That's Been Observed Only Once Before. Will History Repeat Itself?
Bars·28m ago
币安将支持Cardano（ADA）网络升级及硬分叉
PANews·28m ago
AST SpaceMobile: Shares Sink 17% After Pricing a $1 Billion Convertible-Note Offering, But Dilution Risk Is Smaller Than It Looks (NASDAQ:ASTS)
Bars·41m ago
GIFT Nifty Signals Flat Start As Global Chip Sell-Off, Crude Oil Prices Keep Markets On Edge
5paisa·43m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.